Loading asset research
Vogenx Inc Common Stock
VOGXNasdaq · USD · StocksQuote as of · Exchange session not verified$32.71
+9.54%
Today
VOGX
Loading 1D prices…
Market cap
$485.9M
Volume
98.3K
52w high
$35.5052w low
$12.95Company profile
Vogenx Inc Common Stock
Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Raleigh, NC, United States
Employees
4
Fiscal year end
1231
CIK
1903784
Session & valuation
Open$29.57
Previous close$29.86
Day high$33.00
Day low$29.57
30-day avg. volume229.3K
Outstanding shares—
Diluted EPS-$0.2874
Latest annual period
P/E (trailing)-113.82
P/E (forward)—
Price / book-122.97
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CAPRCapricor Therapeutics Inc. Common Stock | $486.6M | $0.00 | — | -$2.26 | +0.90% | Hold |
| RLMDRelmada Therapeutics Inc. Common Stock | $482.1M | $0.00 | — | -$1.45 | +11.30% | Buy |
| SPRYARS Pharmaceuticals Inc. Common Stock | $473.4M | $84.3M | -203.25% | -$1.74 | -6.52% | Buy |
| PBYIPuma Biotechnology Inc Common Stock | $470.8M | $228.4M | +13.62% | $0.61 | -0.55% | Hold |
| IRDOpus Genetics Inc. Common Stock | $502.5M | $14.2M | -349.33% | -$0.80 | -0.49% | Buy |